Ginkgo Bioworks and Givaudan Enter Multi-Program Collaboration to Produce a Series of Ingredients

Through this collaboration, Givaudan plans to sustainably deliver products such as those that are only available in minute quantities in nature, using the natural world as inspiration for an expanded creative palette

Ginkgo Bioworks, Inc. (“Ginkgo”), which is building the leading horizontal platform for cell programming, today announced the signing of a multi-program collaboration with Givaudan, the world’s leading Taste & Wellbeing and Fragrance & Beauty company. Ginkgo, which recently announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), serves customers across industries seeking to develop new and better products. Givaudan will leverage Ginkgo’s long-established expertise in enabling companies to develop bio-based products to produce a number of innovative and sustainable ingredients through fermentation. 

Givaudan has chosen to leverage Ginkgo’s extensive platform to accelerate development and enhance Givaudan’s portfolio of ingredients. Through this collaboration, Givaudan plans to sustainably deliver products such as those that are only available in minute quantities in nature, using the natural world as inspiration for an expanded creative palette.

“We are excited to work with Givaudan to enhance their palette of ingredients used for their product development,” said Jason Kelly, CEO at Ginkgo Bioworks. “Through this close collaboration, we will be able to help Givaudan transform even the rarest and most complex nature-inspired ingredients into more sustainable products for consumers. We believe that biology has the power to enable better and more sustainable products across many industries, from flavors and fragrances, to pharmaceuticals, to farming.”

“Givaudan has long prided itself on being a leader in innovation,” said Allison Haitz, Biotechnology Program Director at Givaudan. “This collaboration with Ginkgo Bioworks is the latest example of our commitment to offering the highest quality, natural products to our customers around the world. We are excited to use biology to unlock more wonders of nature in a sustainable way.”

The collaboration between Ginkgo and Givaudan spans multiple programs, with the possibility of adding more in the future. Companies across numerous industries use Ginkgo’s platform to find more effective, environmentally friendly ways to create products including food ingredients, flavors, cosmetics, medicines, and more. By enabling the design of organisms that can produce valuable biological products, Ginkgo helps accelerate the development of innovative, bio-based solutions to the world’s most pressing environmental challenges.

About Ginkgo Bioworks

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company’s platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. In May 2021, Ginkgo announced a business combination with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), which, if completed, will result in Ginkgo, through a parent entity, Ginkgo Bioworks Holdings, Inc., becoming a public company. The transaction is expected to close in the third quarter of 2021, subject to regulatory and shareholder approvals, and other customary closing conditions.

About Givaudan

Givaudan is a global leading company in taste and wellbeing, and fragrance and beauty. With its heritage stretching back over 250 years, the Company has a long history of innovating scents and tastes. From a favourite drink to your daily meal, from prestige perfumes to cosmetics and laundry care, its creations inspire emotions and delight millions of consumers the world over. The Company is committed to driving purpose-led, long-term growth while leading the way to improve happiness and health for people and nature. In the fiscal year 2020, the Company employed almost 16,000 people worldwide and achieved sales of CHF 6.3 billion and a free cash flow of 12.8% of sales. 

Source

Ginkgo Bioworks, press release, 2021-08-30.

Supplier

Ginkgo BioWorks
Givaudan

Share